8-K/A: Presidio Property Trust Corrects Earnings Report, Net Loss Reported for 2024

Sentiment:

Earnings Release Correction


Presidio Property Trust issues a corrected earnings press release, revising the net real estate assets figure for the year ended December 31, 2024, and reporting a net loss attributable to common stockholders.

Worse than expectedThe company reported a net loss of $27.9 million, a significant decrease compared to the net gain of $8.0 million in the previous year.

Summary

  • Presidio Property Trust corrected its earnings press release on April 7, 2025, to reflect the correct net real estate assets figure for the year ended December 31, 2024.
  • The company reported a net loss attributable to common stockholders of approximately $27.9 million, or ($2.25) per basic and diluted share, for the year ended December 31, 2024, compared to a net gain of approximately $8.0 million, or ($0.68) per basic and diluted share for the year ended December 31, 2023.
  • Total revenue increased by approximately $1.3 million, or 7.3%, to approximately $18.9 million for the year ended December 31, 2024, compared to approximately $17.6 million for the same period in 2023.
  • As of December 31, 2024, the company had approximately $127.6 million in net real estate assets, including 78 model homes, compared to approximately $144.2 million in net real estate assets, including 110 model homes at December 31, 2023.
  • General and administrative expenses increased by approximately $0.7 million, or 10.8%, to approximately $7.5 million for the year ended December 31, 2024, compared to approximately $6.8 million for the same period in 2023.
  • The company recognized a non-cash impairment charge of approximately $2.0 million on goodwill and real estate assets during the year ended December 31, 2024.
  • The company sold 51 model homes for approximately $24.8 million and recognized a gain of approximately $3.4 million during the year ended December 31, 2024.
  • The company's investments in Conduit's common stock and warrants resulted in a net loss on investment for the year ended December 31, 2024, totaling approximately $17.9 million.
  • Interest expense, including amortization of deferred finance charges, increased by approximately $1.0 million, or 20.9%, to approximately $6.1 million for the year ended December 31, 2024.
  • FFO (non-GAAP) increased by approximately $2.8 million to approximately $(3.4 million) from $(6.2 million) for the years ended December 31, 2024 and 2023, respectively.
  • Core FFO (non-GAAP) increased by about $3.2 million, from approximately $(5.2 million) for the year ended December 31, 2023, to approximately $(2.0 million) for the year ended December 31, 2024.
  • The company acquired 19 model home properties for $9.7 million during the year ended December 31, 2024, consisting of cash payments of $3.0 million and mortgage notes of $6.7 million.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the reported net loss, despite some positive aspects like revenue growth and gains from model home sales; the correction of the earnings report also introduces a degree of uncertainty.

Positives

  • Total revenue increased by 7.3% to $18.9 million in 2024.
  • The company sold 51 model homes for $24.8 million, resulting in a gain of $3.4 million.
  • FFO increased by $2.8 million to $(3.4 million), and Core FFO increased by $3.2 million to $(2.0 million).
  • The company acquired 19 model home properties for $9.7 million.

Negatives

  • The company reported a net loss of $27.9 million, or ($2.25) per share, for 2024, a decrease compared to a net gain of $8.0 million, or ($0.68) per share, in 2023.
  • General and administrative expenses increased by approximately $0.7 million, or 10.8%, to approximately $7.5 million for the year ended December 31, 2024.
  • A $2.0 million non-cash impairment charge was recognized on goodwill and real estate assets.
  • The company's investment in Conduit Pharmaceuticals resulted in a net loss of $17.9 million.

Risks

  • The company is susceptible to changing market conditions in the geographic areas where its properties are located.
  • The company's reliance on model home properties leased to homebuilders exposes it to risks associated with the housing market.
  • The company's investment in Conduit Pharmaceuticals is subject to market fluctuations and the success of Conduit's business.

Future Outlook

The company's overall leasing outlook is positive for 2025, and they remain focused on identifying new acquisition opportunities during 2025.

Management Comments

  • We are pleased to report our 2024 earnings, continuing the strong rent collections that we have seen over the last few years, resulting in an increase to rental income during the year, said Jack Heilbron, the Company's President and Chief Executive Officer.
  • Our overall leasing outlook is positive for 2025 said Gary Katz, the Company's Chief Investment Officer.
  • We are pleased with our 2024 model home activity for both the acquisition and resale segments, said Steve Hightower, President of the Model Home Division.
  • So far, the first quarter of 2025 is preforming as we expected.

Industry Context

Presidio operates in the REIT sector, focusing on diversified real estate holdings including model homes, office, industrial, and retail properties; the performance is influenced by broader economic trends, interest rates, and the housing market.

Comparison to Industry Standards

  • Comparing Presidio's FFO and Core FFO to other small-cap REITs reveals its relative operational efficiency and profitability.
  • Companies like Gladstone Commercial Corporation (GOOD) and Armada Hoffler Properties (AHH) are comparable diversified REITs, and benchmarking against their metrics provides insights into Presidio's performance.
  • Presidio's model home strategy is unique, and its success depends on the strength of the housing market in its operating regions, similar to how homebuilder REITs like American Homes 4 Rent (AMH) are affected by housing market dynamics.

Stakeholder Impact

  • Shareholders will be concerned about the net loss and the decrease in net real estate assets.
  • Employees may be affected by potential changes in strategy or operations due to the financial results.
  • Tenants and partners may be impacted by the company's ability to invest in and maintain its properties.

Next Steps

  • The company will continue to focus on identifying new acquisition opportunities during 2025.
  • The company expects interest expense to decrease with the sale of commercial properties in 2025 until additional financing is acquired in connection with new real estate purchases.

Key Dates

DateDescription
2023-12-31Year ended December 31, 2023 financial results.
2024-12-31Year ended December 31, 2024 financial results.
2025-03-31Original Form 8-K filing date and initial earnings press release date.
2025-04-07Date of corrected earnings press release.

Keywords

Presidio Property Trust, earnings, REIT, real estate, model homes, financial results, net loss, revenue, FFO, Core FFO, impairment, Conduit Pharmaceuticals

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.